Neovasc (NVCN) Misses Q1 EPS by 2c

Neovasc (NASDAQ: NVCN) reported Q1 EPS of ($0.10), $0.02 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $1.48 million versus the consensus estimate of $2.63 million.

For earnings history and earnings-related data on Neovasc (NVCN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c